72 research outputs found

    WHOOPING CRANE TITERS TO EASTERN EQUINE ENCEPHALITIS VACCINATIONS

    Get PDF
    In 1984 an epizootic of eastern equine encephalitis (EEE) virus killed 7 of 39 (18%) whooping cranes in captivity at the Patuxent Wildlife Research Center in Laurel, Maryland, USA. Since that time whooping cranes have been vaccinated with a human EEE vaccine. This vaccine was unavailable for several years, necessitating use of an equine vaccine in the cranes. This study compared the antibody titers measured for three years using the human vaccine with those measured for two years using the equine form. Whooping cranes developed similarly elevated titers in one year using the human vaccine and both years using the equine vaccine. However, in two years where the human vaccine was used, the whooping cranes developed significantly lower titers compared to other years

    Liver lesions in winter flounder (Pseudopleuronectes americanus) from Jamaica Bay, New York: Indications of environmental degradation

    Get PDF
    Liver sections of winter flounder (Pseudopleuronectes americanus) collected from Jamaica Bay and Shinnecock Bay, New York, in 1989, were examined microscopically to determine the pervasiveness of liver lesions observed previously in Jamaica Bay winter flounder. Neoplastic lesions were not detected in fish from Jamaica Bay or the Shinnecock Bay reference site. Twenty-two percent of Jamaica Bay winter flounder examined (n=103) had unusual vacuolization of hepatocytes and biliary pre-ductal and ductal cells (referred to hereafter as the vacuolated cell lesion). The lesion, identical to that found in 25% of Jamaica Bay winter flounder examined in 1988, has previously been identified in fishes taken from highly polluted regions of the Atlantic coast (e.g., Boston Harbor, Massachusetts, and Black Rock Harbor, Connecticut). Prevalence of the vacuolated cell lesion in winter flounder from Jamaica Bay was significantly greater (

    Reproductive Biology of the Green Turtle (Chelonia mydas) at Tern Island, French Frigate Shoals, Hawai'i

    Get PDF
    We monitored nesting of the green turtle (Chelonia mydas Linnaeus) on Tern Island, French Frigate Shoals, in the Northwestern Hawaiian Islands from 1986 through 1991. Egg oviposition occurred between 26 April and 20 October. Nesting peaked between mid-June and early August. Hatchlings emerged between 8 July and 27 December. Hatchling emergence peaked between mid-August and early October. Mean incubation period was 66.0 (range 53-97) days. Mean clutch size was 92.4 (range 33-150) eggs. Mean hatching success was 78.6% when averaged over success of individual nests and 81.1% when calculated as percentage of total number of eggs. Natural hatchling emergence was 71.1 %, based on percentage of total number of eggs. Live and dead hatchlings were found when nests were excavated and accounted for 10.0% of the eggs. Incubation periods tended to be longer in early and late portions of the season than in midseason, and incubation periods tended to decrease the farther inland the nest was situated from the high tide line. Maximum hatching success occurred at an incubation length of 66.7 days. Other trends indicated that nesting peaked near 5 July when conditions produced a near optimal incubation period for yielding maximum hatching success

    Absorption and biotransformation of polybrominated diphenyl ethers DE-71 and DE-79 in chicken (\u3ci\u3eGallus gallus\u3c/i\u3e), mallard (\u3ci\u3eAnas platyrhynchos\u3c/i\u3e), American kestrel (\u3ci\u3eFalco sparverius\u3c/i\u3e) and black-crowned night-heron (\u3ci\u3eNycticorax nycticorax\u3c/i\u3e) eggs

    Get PDF
    We recently reported that air cell administration of penta-brominated diphenyl ether (penta-BDE; DE-71) evokes biochemical and immunologic effects in chicken (Gallus gallus) embryos at very low doses, and impairs pipping (i.e., stage immediately prior to hatching) and hatching success at 1.8 µg g-1 egg (actual dose absorbed) in American kestrels (Falco sparverius). In the present study, absorption of polybrominated diphenyl ether (PBDE) congeners was measured following air cell administration of a penta-BDE mixture (11.1 lg DE-71 g-1 egg) or an octa-brominated diphenyl ether mixture (octa BDE; DE-79; 15.4 lg DE-79 g-1 egg). Uptake of PBDE congeners was measured at 24 h post-injection, midway through incubation, and at pipping in chicken, mallard (Anas platyrhynchos), and American kestrel egg contents, and at the end of incubation in black-crowned night-heron (Nycticorax nycticorax) egg contents. Absorption of penta-BDE and octa-BDE from the air cell into egg contents occurred throughout incubation; at pipping, up to 29.6% of penta-BDE was absorbed, but only 1.40–6.48% of octa-BDE was absorbed. Higher brominated congeners appeared to be absorbed more slowly than lower brominated congeners, and uptake rate was inversely proportional to the log Kow of predominant BDE congeners. Six congeners or co-eluting pairs of congeners were detected in penta-BDE-treated eggs that were not found in the dosing solution suggesting debromination in the developing embryo, extraembryonic membranes, and possibly even in the air cell membrane. This study demonstrates the importance of determining the fraction of xenobiotic absorbed into the egg following air cell administration for estimation of the lowest-observed-effect level

    Ergogenic effects of betaine supplementation on strength and power performance

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>We investigated the ergogenic effects of betaine (B) supplementation on strength and power performance.</p> <p>Methods</p> <p>Twelve men (mean ± SD age, 21 ± 3 yr; mass, 79.1 ± 10.7 kg) with a minimum of 3 months resistance training completed two 14-day experimental trials separated by a 14-day washout period, in a balanced, randomized, double-blind, repeated measures, crossover design. Prior to and following 14 days of twice daily B or placebo (P) supplementation, subjects completed two consecutive days (D1 and D2) of a standardized high intensity strength/power resistance exercise challenge (REC). Performance included bench, squat, and jump tests.</p> <p>Results</p> <p>Following 14-days of B supplementation, D1 and D2 bench throw power (1779 ± 90 and 1788 ± 34 W, respectively) and isometric bench press force (2922 ± 297 and 2503 ± 28 N, respectively) were increased (p < 0.05) during REC compared to pre-supplementation values (1534 ± 30 and 1498 ± 29 W, respectively; 2345 ± 64 and 2423 ± 84 N, respectively) and corresponding P values (1374 ± 128 and 1523 ± 39 W; 2175 ± 92 and 2128 ± 56 N, respectively). Compared to pre-supplementation, vertical jump power and isometric squat force increased (p < 0.05) on D1 and D2 following B supplementation. However, there were no differences in jump squat power or the number of bench press or squat repetitions.</p> <p>Conclusion</p> <p>B supplementation increased power, force and maintenance of these measures in selected performance measures, and these were more apparent in the smaller upper-body muscle groups.</p

    Evaluating the Effect of Beauty on Labor Market Outcomes: A Review of the Literature.

    Full text link
    An important underlying determinant of wage discrimination, as well as the gender wage gap is the way the labor market rewards individual physical attractiveness. This article surveys the extensive empirical literature of the effect of physical attractiveness on labor market outcomes. Particular attention is given to the channels through which attractiveness may affect individual labor market outcomes and the way attractiveness affects gender wage differentials. Further research is needed on the effect of attractiveness within occupations in order to provide more evidence on its productivity-enhancing channel of transmission and the effect this has on the gender wage gap

    Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world

    Get PDF
    Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection

    The Somatic Genomic Landscape of Glioblastoma

    Get PDF
    We describe the landscape of somatic genomic alterations based on multi-dimensional and comprehensive characterization of more than 500 glioblastoma tumors (GBMs). We identify several novel mutated genes as well as complex rearrangements of signature receptors including EGFR and PDGFRA. TERT promoter mutations are shown to correlate with elevated mRNA expression, supporting a role in telomerase reactivation. Correlative analyses confirm that the survival advantage of the proneural subtype is conferred by the G-CIMP phenotype, and MGMT DNA methylation may be a predictive biomarker for treatment response only in classical subtype GBM. Integrative analysis of genomic and proteomic profiles challenges the notion of therapeutic inhibition of a pathway as an alternative to inhibition of the target itself. These data will facilitate the discovery of therapeutic and diagnostic target candidates, the validation of research and clinical observations and the generation of unanticipated hypotheses that can advance our molecular understanding of this lethal cancer

    A multimodal cell census and atlas of the mammalian primary motor cortex

    Get PDF
    ABSTRACT We report the generation of a multimodal cell census and atlas of the mammalian primary motor cortex (MOp or M1) as the initial product of the BRAIN Initiative Cell Census Network (BICCN). This was achieved by coordinated large-scale analyses of single-cell transcriptomes, chromatin accessibility, DNA methylomes, spatially resolved single-cell transcriptomes, morphological and electrophysiological properties, and cellular resolution input-output mapping, integrated through cross-modal computational analysis. Together, our results advance the collective knowledge and understanding of brain cell type organization: First, our study reveals a unified molecular genetic landscape of cortical cell types that congruently integrates their transcriptome, open chromatin and DNA methylation maps. Second, cross-species analysis achieves a unified taxonomy of transcriptomic types and their hierarchical organization that are conserved from mouse to marmoset and human. Third, cross-modal analysis provides compelling evidence for the epigenomic, transcriptomic, and gene regulatory basis of neuronal phenotypes such as their physiological and anatomical properties, demonstrating the biological validity and genomic underpinning of neuron types and subtypes. Fourth, in situ single-cell transcriptomics provides a spatially-resolved cell type atlas of the motor cortex. Fifth, integrated transcriptomic, epigenomic and anatomical analyses reveal the correspondence between neural circuits and transcriptomic cell types. We further present an extensive genetic toolset for targeting and fate mapping glutamatergic projection neuron types toward linking their developmental trajectory to their circuit function. Together, our results establish a unified and mechanistic framework of neuronal cell type organization that integrates multi-layered molecular genetic and spatial information with multi-faceted phenotypic properties
    corecore